For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.
He first came into contact with the stock market and shares during his banking apprenticeship. After completing this in 2000, he gained his first journalistic experience in the editorial department of a financial portal. During his subsequent studies in business administration, he also worked in the area of investor relations.
Since then, he has remained true to the capital markets and is excited to report on every newly discovered interesting story - as well as on long-standing success stories.
Commented by Fabian Lorenz
Commented by Fabian Lorenz on June 18th, 2024 | 06:30 CEST
Price jump at TUI! Bayer share price slumps! Globex Mining makes millions!
TUI shares were among the day's winners on the German stock market yesterday. The tourism group benefited not only from positive analyst comments but also from the FTI bankruptcy. Can the share now end its months-long sideways movement? There are also good reasons for higher prices at Globex Mining. The mining incubator recently received CAD 3 million from the gold group Agnico Eagle - and that is not the end of the story. The latest analyst comments on Bayer shares are not very promising. Yesterday's DAX share price reaction was correspondingly negative. However, the management was optimistic.
Read
Commented by Fabian Lorenz on June 13th, 2024 | 07:00 CEST
Stocks on the verge of a breakout! Rheinmetall, TUI, Desert Gold
Will Rheinmetall soon reach a new all-time high? An insider thinks so and is buying a sizeable block of shares in the armaments group. The news situation could hardly be better for the DAX-listed company. The price of gold could also break out and rise to USD 2,700 in the next wave, according to a renowned expert. Desert Gold should benefit noticeably from this. The Company's market capitalization is only a fraction of the proven gold resource, and drilling continues. And what is TUI doing? The share is not making any real progress. However, it should benefit from the FTI collapse, and the crucial summer season brings a high booking volume.
Read
Commented by Fabian Lorenz on June 12th, 2024 | 07:00 CEST
Shock at Plug Power! Thyssenkrupp Nucera and Altech Advanced Materials with up to 100% upside potential!
Alarm at Plug Power. After the price jump in May, the share has gone into reverse again and lost 10% of its value in just a few days. Financing worth billions for the struggling hydrogen pioneer is uncertain, bringing the Company's potential insolvency back into the focus of investors. German hydrogen hopeful Thyssenkrupp Nucera received positive analyst comments. Could the share perhaps even double in value? And what is Altech Advanced Materials doing? The shares of the German battery hopeful have bottomed out and may offer an entry opportunity. The market potential for Altech is huge.
Read
Commented by Fabian Lorenz on June 6th, 2024 | 07:15 CEST
Invest in these stocks now! BYD, Varta, Royal Helium!
Those who invest in latecomer stocks now could be rewarded. After all, the high-flyers of 2024 from the fields of artificial intelligence and armaments are anything but cheaply valued. Here are three stocks that could be worth buying now, at least at first glance. BYD has bucked the industry trend by publishing positive sales figures, is making progress in autonomous driving, and analysts are optimistic. Those looking to benefit indirectly from the boom in armaments or quantum computers should consider Royal Helium. A capital increase has injected fresh money into the Company's coffers, and the helium producer can take off again. And what about problem child Varta? The struggling battery manufacturer has found a new CEO, but the old problems remain.
Read
Commented by Fabian Lorenz on June 5th, 2024 | 06:45 CEST
Share price rise! Nel ASA, Rheinmetall, Almonty Industries - Which momentum share is running out of steam?
Will the Rheinmetall share end its consolidation and rise to a new all-time high? The chances are good. The armaments group is receiving one order after another - most recently from the German government and Lithuania. Analysts believe the share has around 30% potential. The Almonty Industries share has gained around 30% in recent months. The momentum for the tungsten producer is likely to continue. In China - the number one producer country - prices are rising to a 10-year high, and production is falling at the same time. This could hardly be a better time for Almonty to commission a new mine. The share price momentum at Nel ASA seems to be running out of steam. Or can the latest news provide support?
Read
Commented by Fabian Lorenz on May 30th, 2024 | 07:30 CEST
Takeover fever? Nel, Super Micro Computer, Kraken Energy
In the slipstream of Nvidia, the Super Micro Computer share is heading back towards an all-time high. The temporary dip following the strong quarterly figures - which fell short of even higher expectations - has ended, and the share is targeting the USD 1,000 mark. Energy producers are increasingly under the spotlight as the AI boom is set to surge energy demand. The billion-dollar takeover of Atlantica Sustainable Infrastructure by the private equity company Energy Capital Partners is currently underway. It is evident that some of the energy demand will have to be met by nuclear energy, benefiting companies like Kraken Energy, which is developing new uranium deposits in the US. Additionally, takeover speculation has recently driven up Nel ASA's share price, but is the rally already over?
Read
Commented by Fabian Lorenz on May 29th, 2024 | 07:00 CEST
Biotech stocks with a comeback! BioNTech, Evotec, Vidac Pharma
Avian flu has caused vaccine stocks such as BioNTech, Moderna and CureVac to soar in the past week; however, more is needed to ensure a sustainable comeback. BioNTech plans to achieve this with cancer drugs. In an interview with "Handelsblatt", BioNTech's CEO expressed his optimism about significantly reducing the mortality rate. The Mainz-based company plans to launch its first drugs on the market as early as 2026. Vidac Pharma is pursuing a revolutionary approach in the fight against cancer. The London-based biotech company has published promising study data and is being traded as a takeover candidate. And what about Evotec? The problem child of the current year has extended a partnership but continues to search for a trigger to drive its stock up.
Read
Commented by Fabian Lorenz on May 23rd, 2024 | 09:00 CEST
Caution with Hensoldt and Siemens Energy? Record numbers for Saturn Oil + Gas!
The shares of Hensoldt and Siemens Energy are among the stars of the current year. However, analysts are advising caution with both. Although the order intake at Hensoldt is convincing, there are also disappointments. Analysts see a significant risk to Siemens Energy's share price, which is not mitigated by their intention to sell in India. In contrast, Saturn Oil & Gas' record figures for the first quarter are convincing and offer share price potential. With the latest takeover, the oil producer aims to move up into the league of mid-sized producers and, thus, into a new league. Analysts are likely to raise their estimates upward soon.
Read
Commented by Fabian Lorenz on May 22nd, 2024 | 08:00 CEST
Hydrogen stocks with top news! Plug Power, Thyssenkrupp Nucera and dynaCERT in focus!
Despite negative quarterly figures, the Plug Power share has developed positively in recent days. Is this the turnaround for the hydrogen pureplay? The Americans recently reported progress on a mega-project. dynaCERT is strengthening its position with an industry expert and former Daimler manager. The technology company is thus preparing for the breakthrough of its products aimed at reducing emissions in diesel vehicles. All that is missing now is VERRA certification for the issue of CO2 certificates. At Thyssenkrupp Nucera, the quarterly figures currently have to be digested. Analyst comments sound somewhat disappointed, but the price targets still leave room for growth for the German hydrogen hopeful.
Read
Commented by Fabian Lorenz on May 16th, 2024 | 08:00 CEST
Share price shock at Siemens Energy! What are BioNTech and Cardiol Therapeutics doing?
The Siemens Energy share has been one of the surprises of recent months. It has more than doubled since the beginning of the year. Is a crash now imminent? Yes, if you believe Bernstein. Their analysts are shocking us with a horror price target. The Cardiol Therapeutics share performed even better than Siemens Energy in 2024. Despite the 150% rally, analysts see upside potential for the cardiovascular disease specialist. Things will get really exciting at the beginning of June when new study results are due. BioNTech, on the other hand, is currently failing to convince analysts. Reactions to the latest quarterly figures were modest.
Read